Epidemiological and clinical features of functional dyspepsia in a region with a high incidence of esophageal cancer in China

Nan Hu, Kun Wang, Li Zhang, Zuo-Jing Liu, Zhu Jin, Rong-Li Cui, He-Jun Zhang, Zhong-Hu He, Yang Ke, Li-Ping Duan, Nan Hu, Kun Wang, Li Zhang, Zuo-Jing Liu, Zhu Jin, Rong-Li Cui, He-Jun Zhang, Zhong-Hu He, Yang Ke, Li-Ping Duan

Abstract

Background: Functional dyspepsia (FD) has rarely been investigated in areas with a high prevalence of esophageal squamous cell carcinoma (ESCC). This study aims to reveal the epidemiological and clinical features of FD and organic dyspepsia (OD) in such a population.

Methods: A middle-aged and elderly population-based study was conducted in a region with a high incidence of ESCC. All participants completed the Gastroesophageal Reflux Disease Questionnaire and Functional Gastrointestinal Disease Rome III Diagnostic Questionnaire, and they underwent gastroscopy. After exclusion of gastroesophageal reflux disease, uninvestigated dyspepsia (UID) was divided into OD and FD for further analyses.

Results: A total of 2916 participants were enrolled from July 2013 to March 2014 in China. We detected 166 UID cases with questionnaires, in which 17 patients with OD and 149 with FD were diagnosed via gastroscopy. OD cases presented as reflux esophagitis (RE), ESCC, and duodenal ulcer. Heartburn (52.94%) and reflux (29.41%) were common in OD, but no symptomatic differences were found between FD and OD. Male sex, low education level, and liquid food were the risk factors for OD, while frequent fresh vegetable consumption was a protective factor. FD included 56 (37.58%) cases of postprandial distress syndrome (PDS), 52 (34.89%) of epigastric pain syndrome (EPS), nine (6.04%) of PDS + EPS, and 32 (21.48%) of FD + functional esophageal disorders. The Helicobacter pylori infection rate in FD patients was not higher than that in the control group (34.23% vs. 42.26%, P = 0.240). Frequent spicy food consumption was associated with PDS (odds ratio [OR]: 2.088, 95% confidence interval [CI]: 1.028-4.243), while consumption of deep well water was protective for PDS (OR: 0.431, 95% CI: 0.251-0.741).

Conclusions: The prevalence of FD was 5.11% in the studied population. Gastroscopy should be prescribed for dyspepsia patients in case that ESCC and RE would be missed in UID cases diagnosed solely by the Rome III questionnaire.

Trial registration: ClinicalTrials.gov, NCT01688908; https://ichgcp.net/clinical-trials-registry/NCT01688908.

Conflict of interest statement

None.

Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license.

Figures

Figure 1
Figure 1
Study flow chart and the distribution of upper GI tract diseases based on questionnaire and gastroscopy findings. CC: Cardiac cancer; CRF: Case report form; DU: Duodenal ulcer; EPS: Epigastric pain syndrome; ESCC: Esophageal squamous cell cancer; FD: Functional dyspepsia; FED: Functional esophageal diseases; FD + FED: Co-occurrence of FD and FED; GI: Gastrointestinal; GerdQ: Gastroesophageal Reflux Disease Questionnaire; GC: Gastric cancer; GU: Gastric ulcer; NERD: Non-erosive reflux disease; PDS: Postprandial distress syndrome; PDS + EPS: Co-occurrence of PDS and EPS; Rome III: The Chinese version of the Adult Functional Gastrointestinal Disease Rome III Diagnostic Questionnaire; RE: Reflux esophagitis.
Figure 2
Figure 2
Distribution of FD and OD in UID. DU: Duodenal ulcer; EPS: Epigastric pain syndrome; ESCC: Esophageal squamous cell cancer; FD: Functional dyspepsia; FD + FED: Co-occurrence of FD and functional esophageal disorders; OD: Organic dyspepsia; PDS: Postprandial distress syndrome; PDS + EPS: Co-occurrence of PDS and EPS; RE: Reflux esophagitis; UID: Uninvestigated dyspepsia.
Figure 3
Figure 3
Distribution of symptoms in FD and its subtypes. ∗P < 0.050; †P < 0.010; ‡P < 0.001. EPS: Epigastric pain syndrome; FD + FED: Co-occurrence of functional dyspepsia and functional esophageal disorder; PDS: Postprandial distress syndrome; PDS + EPS: Co-occurrence of PDS and EPS.

References

    1. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. . Functional gastroduodenal disorders. Gastroenterology 2006; 130:1466–1479. doi: 10.1053/j.gastro.2005.11.059.
    1. Mahadeva S, Goh KL. Epidemiology of functional dyspepsia: a global perspective. World J Gastroenterol 2006; 12:2661–2666. doi: 10.3748/wjg.v12.i17.2661.
    1. Enck P, Azpiroz F, Boeckxstaens G, Elsenbruch S, Feinle-Bisset C, Holtmann G, et al. . Functional dyspepsia. Nat Rev Dis Primers 2017; 3:17081.doi: 10.1038/nrdp.2017.81.
    1. Ghoshal UC, Singh R, Chang FY, Hou X, Wong BCY, Kachintorn U, et al. . Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction. J Neurogastroenterol Motil 2011; 17:235–244. doi: 10.5056/jnm.2011.17.3.235.
    1. Zhao Y, Zou D, Wang R, Ma X, Yan X, Man X, et al. . Dyspepsia and irritable bowel syndrome in China: a population-based endoscopy study of prevalence and impact. Aliment Pharmacol Ther 2010; 32:562–572. doi: 10.1111/j.1365-2036.2010.04376.x.
    1. Li Y, Nie Y, Sha W, Su H. The link between psychosocial factors and functional dyspepsia: an epidemiological study. Chin Med J (Engl) 2002; 115:1082–1084.
    1. Zhang AZ, Wang QC, Huang KM, Huang JG, Zhou CH, Sun FQ, et al. . Prevalence of depression and anxiety in patients with chronic digestive system diseases: a multicenter epidemiological study. World J Gastroenterol 2016; 22:9437–9444. doi: 10.3748/wjg.v22.i42.9437.
    1. Xu JH, Lai Y, Zhuang LP, Huang CZ, Li CQ, Chen QK, et al. . Certain dietary habits contribute to the functional dyspepsia in South China Rural Area. Med Sci Monit 2017; 23:3942–3951. doi: 10.12659/msm.902705.
    1. Dong YY, Chen FX, Yu YB, Du C, Qi QQ, Liu H, et al. . A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 2013; 8:e54183.doi: 10.1371/journal.pone.0054183.
    1. Liu M, Liu Z, Cai H, Guo C, Li X, Zhang C, et al. . A model to identify individuals at high risk for esophageal squamous cell carcinoma and precancerous lesions in regions of high prevalence in China. Clin Gastroenterol Hepatol 2017; 15:1538–1546. doi: 10.1016/j.cgh.2017.03.019.
    1. Liu Z, Guo C, He Y, Chen Y, Ji P, Fang Z, et al. . A clinical model predicting the risk of esophageal high-grade lesions in opportunistic screening: a multicenter real-world study in China. Gastrointest Endosc 2020; 91:1253–1260. doi: 10.1016/j.gie.2019.12.038.
    1. Wang K, Zhang L, He ZH, Liu ZJ, Zhang L, Hu N, et al. . A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China. Chin Med J (Engl) 2019; 132:1516–1523. doi: 10.1097/CM9.0000000000000275.
    1. He Z, Liu Z, Liu M, Guo C, Xu R, Li F, et al. . Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial. Gut 2019; 68:198–206. doi: 10.1136/gutjnl-2017-315520.
    1. Ghoshal UC, Gwee KA, Chen M, Gong XR, Pratap N, Hou X, et al. . Development, translation and validation of enhanced Asian Rome III Questionnaires for diagnosis of functional bowel diseases in major Asian languages: a Rome Foundation-Asian Neurogastroenterology and Motility Association Working Team Report. J Neurogastroenterol Motil 2015; 21:83–92. doi: 10.5056/jnm14045.
    1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101:1900–1920. doi: 10.1111/j.1572-0241.2006.00630.x.
    1. Lin SR, Xu GM, Hu PJ, Zhou LY, Chen MH, Ke MY, et al. . Chinese consensus on gastroesophageal reflux disease (GERD): October 2006, Sanya, Hainan Province, China. J Dig Dis 2007; 8:162–169. doi: 10.1111/j.1443-9573.2007.00298.x.
    1. Gastroenterology Branch of Chinese Medical Association. Chinese consensus on chronic gastritis (Shanghai, 2017). Chin J Dig 2017; 37:721–738. doi: 10.3760/cma.j.issn.0254-1432.2017.11.001.
    1. World Health Organization, Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO Classification of Tumours of the Digestive System. 2010.
    1. Xiong LS, Shi Q, Gong XR, Cui Y, Chen MH. The spectra, symptom profiles and overlap of Rome III functional gastrointestinal disorders in a tertiary center in South China. J Dig Dis 2014; 15:538–544. doi: 10.1111/1751-2980.12178.
    1. Kanazawa M, Nakajima S, Oshima T, Whitehead WE, Sperber AD, Palsson OS, et al. . Validity and reliability of the Japanese Version of the Rome III diagnostic Questionnaire for irritable bowel syndrome and functional dyspepsia. J Neurogastroenterol Motil 2015; 21:537–544. doi: 10.5056/jnm15016.
    1. Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut 2015; 64:1049–1057. doi: 10.1136/gutjnl-2014-307843.
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68:394–424. doi: 10.3322/caac.21492.
    1. Chen W, Sun K, Zheng R, Zeng H, Zhang S, Xia C, et al. . Cancer incidence and mortality in China, 2014. Chin J Cancer Res 2018; 30:1–12. doi: 10.21147/j.issn.1000-9604.2018.01.01.
    1. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010; 8:830–837. doi: 10.1016/j.cgh.2010.05.031.
    1. Sardana RK, Chhikara N, Tanwar B, Panghal A. Dietary impact on esophageal cancer in humans: a review. Food Funct 2018; 9:1967–1977. doi: 10.1039/c7fo01908d.
    1. Richter JE, Rubenstein JH. Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 2018; 154:267–276. doi: 10.1053/j.gastro.2017.07.045.
    1. Eusebi LH, Ratnakumaran R, Yuan Y, Solaymani-Dodaran M, Bazzoli F, Ford AC. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut 2018; 67:430–440. doi: 10.1136/gutjnl-2016-313589.
    1. Kusano M, Hosaka H, Yasuoka H, Kawamura O, Kawada A, Kuribayashi S, et al. . New endoscopic classification of cascade stomach, a risk factor for reflux esophagitis. J Gastroenterol 2017; 52:211–217. doi: 10.1007/s00535-016-1214-0.
    1. Moayyedi P, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol 2017; 112:988–1013. doi: 10.1038/ajg.2017.154.
    1. Chen SL, Gwee KA, Lee JS, Miwa H, Suzuki H, Guo P, et al. . Systematic review with meta-analysis: prompt endoscopy as the initial management strategy for uninvestigated dyspepsia in Asia. Aliment Pharmacol Ther 2015; 41:239–252. doi: 10.1111/apt.13028.
    1. Oshima T, Miwa H. Epidemiology of functional gastrointestinal disorders in Japan and in the world. J Neurogastroenterol Motil 2015; 21:320–329. doi: 10.5056/jnm14165.
    1. Matsuzaki J, Suzuki H, Asakura K, Fukushima Y, Inadomi JM, Takebayashi T, et al. . Classification of functional dyspepsia based on concomitant bowel symptoms. Neurogastroenterol Motil 2012; 24:164–325. doi: 10.1111/j.1365-2982.2011.01859.x.
    1. Stanghellini V, Chan FKL, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. . Gastroduodenal disorders. Gastroenterology 2016; 150:1380–1392. doi: 10.1053/j.gastro.2016.02.011.
    1. Kim SE, Kim N, Lee JY, Park KS, Shin JE, Nam K, et al. . Prevalence and risk factors of functional dyspepsia in health check-up population: a Nationwide Multicenter Prospective Study. J Neurogastroenterol Motil 2018; 24:603–613. doi: 10.5056/jnm18068.
    1. Carbone F, Vanuytsel T, Tack J. Analysis of postprandial symptom patterns in subgroups of patients with Rome III or Rome IV functional dyspepsia. Clin Gastroenterol Hepatol 2020; 18:838–846.e3. doi: 10.1016/j.cgh.2019.07.053.
    1. Tack J, Talley NJ. Functional dyspepsia – symptoms, definitions and validity of the Rome III criteria. Nat Rev Gastroenterol Hepatol 2013; 10:134–141. doi: 10.1038/nrgastro.2013.14.
    1. Duncanson KR, Talley NJ, Walker MM, Burrows TL. Food and functional dyspepsia: a systematic review. J Hum Nutr Diet 2018; 31:390–407. doi: 10.1111/jhn.12506.
    1. Goktas Z, Koklu S, Dikmen D, Ozturk O, Yilmaz B, Asil M, et al. . Nutritional habits in functional dyspepsia and its subgroups: a comparative study. Scand J Gastroenterol 2016; 51:903–907. doi: 10.3109/00365521.2016.1164238.
    1. Saneei P, Sadeghi O, Feizi A, Keshteli AH, Daghaghzadeh H, Esmaillzadeh A, et al. . Relationship between spicy food intake and chronic uninvestigated dyspepsia in Iranian adults. J Dig Dis 2016; 17:28–35. doi: 10.1111/1751-2980.12308.
    1. Futagami S, Itoh T, Sakamoto C. Systematic review with meta-analysis: post-infectious functional dyspepsia. Aliment Pharmacol Ther 2015; 41:177–188. doi: 10.1111/apt.13006.
    1. Vanheel H, Vicario M, Vanuytsel T, Van Oudenhove L, Martinez C, Keita AV, et al. . Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia. Gut 2014; 63:262–271. doi: 10.1136/gutjnl-2012-303857.
    1. Holtmann G, Talley NJ. Functional dyspepsia. Curr Opin Gastroenterol 2015; 31:492–498. doi: 10.1097/MOG.0000000000000219.
    1. Wauters L, Nightingale S, Talley NJ, Sulaiman B, Walker MM. Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort. Aliment Pharmacol Ther 2017; 45:1358–1364. doi: 10.1111/apt.14045.
    1. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. . Kyoto global consensus report on Helicobacter pylori gastritis. Gut 2015; 64:1353–1367. doi: 10.1136/gutjnl-2015-309252.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir